You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
ExpreS2ion Biotechnologies – Presentation of Year-end report 2022
Earlier today, Expres2ion Biotechnologies' CEO Bent Frandsen and CFO Keith Alexander presented the company’s Q4 2022 and full-year financials for 2022.
Besides the financial results, the main focus of the Q&A session was around the COVID-19 vaccine candidate and this morning’s announcement from the partner, Bavarian Nordic, about the timeline delay.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 16:34, 15 February 2023.